Carboplatin
KYXATA
Platinum-based Drug
NADAC/unit
N/A
Active Shortage
12 Manufacturers
45 ANDAs
Active Shortages
2026-02-20 Discontinuation of the manufacture of the drug, Ingenus Pharmaceuticals LLC
2026-02-20 Discontinuation of the manufacture of the drug, Ingenus Pharmaceuticals LLC
2025-03-28 Discontinuation due to low sales volume. Supply currently available with June 2025 expiry dating. Wholesaler & Distributor through Marketing partner (Apotex Inc.), Teyro Labs
2025-03-28 Discontinuation due to low sales volume. Supply currently available with November 2025 expiry dating. Wholesaler & Distributor through Marketing partner (Apotex Inc.), Teyro Labs
2023-04-28 Shortage reported, Teva Pharmaceuticals USA, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCAVYXA HOLDINGS LLCEPIC PHARMA LLCEUGIA PHARMA SPECIALITIES LTDFRESENIUS KABI USA LLCGLAND PHARMA LTDHIKMA PHARMACEUTICALS USA INCHOSPIRA INCPHARMACHEMIE BVQILU PHARMACEUTICAL HAINAN CO LTDSANDOZ INCSUN PHARMACEUTICAL INDUSTRIES LTDTEYRO LABS PRIVATE LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.